Skip to content

A study to see what proportion of patients of acute pancreatitis develop vascular complications and how the vascular complications evolve and what is their outcome

A prospective cohort study to analyze the prevalence and natural history of vascular complications of acute pancreatitis.

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2020/05/025024
Enrollment
400
Registered
2020-05-05
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K859- Acute pancreatitis, unspecified

Interventions

None listed

Sponsors

Department of Gastroenterology IPGMER AND SSKM HOSPITAL
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All patients with index episode of Acute Pancreatitis presenting upto four weeks after onset of pain and fulfilling the diagnostic criteria for Acute Pancreatitis and having a baseline contrast enhanced Computed Tomogra-phy(CT) of Abdomen performed according to pancreatic protocol at least 5-7 days after onset of pain.

Exclusion criteria

Exclusion criteria: 1.Patients having previous episodes of presumed or diagnosed Acute Pancreatitis with vascular complications 2. Patients diagnosed to have chronic pancreatitis either at evaluation or during the follow up period. Chronic pancreatitis will be diagnosed when a patient has recurrent episodes of upper abdominal pain of pancreatic origin with the following additional criteria9. (A) Pancreatic calcifications. (B) Moderate or marked ductal lesions (ac-cording to the Cambridge classification) (C). Marked and persistent exocrine insufficiency defined as pancreatic steatorrhea markedly reduced by enzyme supplementation. (D) Typical histology of an adequate histological specimen 3. Patients or parents who are not willing to give consent. 4. Patients who are HIV positive 5. Pregnant females 6. Patients of Recurrent Acute Pancreatitis without previous vascular complications 7. Chronic Pancreatitis 8. Any associated malignancy 9. Cirrhosis and established portal hypertension 10.Patients on antiplatelets/ anticoagulants

Design outcomes

Primary

MeasureTime frame
Primary outcome Incidence, severity and evolution of vascular complication in acute pancreatitis Timepoint: Follow up of 6 months after enrollment

Secondary

MeasureTime frame
Association of vascular complications with the etiology and severity of Acute pancreatitisTimepoint: Follow up of 6 months after enrollment

Countries

India

Contacts

Public ContactNIRAJ AGARWALA

IPGMER AND SSKM Hospital, Kolkata

dockdas@gmail.com9830349787

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026